<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	>
<channel>
	<title>Comments on: Trying To Forget Alzheimer&#8217;s Disappointments</title>
	<atom:link href="http://www.pharmalot.com/2008/07/trying-to-forget-alzheimers-disappointments/feed" rel="self" type="application/rss+xml" />
	<link>http://www.pharmalot.com/2008/07/trying-to-forget-alzheimers-disappointments/</link>
	<description>News, Comment and Conversation</description>
	<pubDate>Fri, 10 Feb 2012 20:32:38 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.6.2</generator>
		<item>
		<title>By: JK</title>
		<link>http://www.pharmalot.com/2008/07/trying-to-forget-alzheimers-disappointments/#comment-368071</link>
		<dc:creator>JK</dc:creator>
		<pubDate>Tue, 29 Jul 2008 14:09:36 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/?p=14849#comment-368071</guid>
		<description>I don't think we'll be disappointed for long. See presentation at ICAD 2008 today on
"Tau aggregation inhibitor (TAI) therapy with remberTM arrests disease progression in mild and moderate Alzheimer's disease over 50 weeks". 
The results are better than any existing Alzheimer drug.</description>
		<content:encoded><![CDATA[<p>I don&#8217;t think we&#8217;ll be disappointed for long. See presentation at ICAD 2008 today on<br />
&#8220;Tau aggregation inhibitor (TAI) therapy with remberTM arrests disease progression in mild and moderate Alzheimer&#8217;s disease over 50 weeks&#8221;.<br />
The results are better than any existing Alzheimer drug.</p>
]]></content:encoded>
	</item>
</channel>
</rss>

<!-- Dynamic Page Served (once) in 0.148 seconds -->

